Neora/Nerium investigated Neora, formerly known as Nerium International, a Texas-based multilevel marketing company that sells a line of skin care products, as well as supplements, and found that the company and its distributors have used unsubstantiated disease-treatment claims to market products and atypical income claims to recruit distributors.


  • Notified company of findings
  • Filed complaint with FTC
  • Filed complaint with TX attorney general
  • Notified the DSA
  • FTC sued company
Deceptive company ad


February 14

As part of its 2023 investigation into 100 MLM companies, notifies Neora of its findings that the company has used atypical income claims to market its business opportunity.

September 28

After a non-jury trial, the court finds that the FTC did not provide enough evidence to support its claims against Nerium/Neora and enters a final judgment in favor of the company.

August 31

The court dismisses Neora’s lawsuit against the FTC, finding that the company’s claims are not ripe for adjudication.

November 1

The FTC sues Nerium (under its new name Neora) and its CEO Jeff Olson in federal court alleging that the company operates as an illegal pyramid scheme and falsely promises recruits they will achieve financial independence if they join the scheme.  The lawsuit also alleges that it deceptively promotes EHT supplements as an antidote to concussions, chronic traumatic encephalopathy caused by repetitive brain trauma, Alzheimer’s disease and Parkinson’s disease.  The same day, Nerium sues the FTC for allegedly attempting to improperly change direct selling laws.

December 18

As part of its 2017 investigation into all DSA-member companies, notifies Nerium of continued findings that it uses atypical income claims to market the business opportunity.

July 15

The DSA sends an email regarding Nerium.

July 11 responds to Nerium to address the inaccuracies contained in its July 6 letter, as well as report’s findings of an additional 50 disease treatment claims being made by Nerium distributors.

July 6

Nerium sends a letter to to, among other things, inform us that Nerium’s Compliance Department is undertaking a review of the web posts referenced in’s May 30, 2017 letter.

June 8

The DSA sends an email to Nerium regarding’s investigation.

May 30

After finding hundreds more inappropriate health and income claims published on the internet (some 12 months after putting Nerium on notice), notifies the Code of Ethics Administrator for the Direct Selling Association (of which Nerium is a member), as well as company officials, the FTC, and the Texas Attorney General, of the company’s continuing transgressions.

July 12

After auditing the original sampling of deceptive claims being made about Nerium’s products and business opportunity that provided to the company, and finding that the majority of the claims were still up on the Internet, files complaint letters with the Federal Trade Commission and Texas Attorney General urging them both to investigate the company and take appropriate enforcement action.

June 17 responds to Nerium.

June 14

Nerium informs that it is taking immediate action to address the deceptive claims at issue, including contacting its distributors, requesting the removal of deceptive claims, and educating its distributors about how to make proper claims about the products and business opportunity.

June 6 sends a warning letter to Nerium notifying it of’s findings and asking that the company remedy the deceptive marketing immediately.


The Latest


Show More

Class-Action Tracker

Nerium Pyramid Scheme Claims

Class Action

Nerium Pyramid Scheme Claims

June 2020: The district court case was voluntarily dismissed pursuant to the terms of a confidential settlement agreement. December 2019: The appeal was dismissed for lack of jurisdiction. September 2019:…